Alzheimer’s Drug Shown To Slow Down Disease by Nearly 30% In Clinical Trial
Alzheimer’s disease is a devasting neurological disorder that affects memory, thinking, and behavior for which there is no cure. However, there is some encouraging news for those with Alzheimer’s and their families. Pharmaceutical companies Eisai and Biogen have worked together to create lecanemab, a drug that has been designed to slow cognitive decline in people with dementia and Alzheimer’s.